CTRANEUTRAL

Return on Equity (ROE)

11.4%

Updated 488h ago

Sector Performance

43th percentile

CTRA

11.4%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

CTRA's current Return on Equity (ROE) of 11.4% means that for every dollar of shareholder equity, the company generated 11.4 cents in profit over the past year — a measure of how efficiently it uses investor capital.

This sits below the sector median of 14.0%, placing CTRA in the 41st percentile among its industry peers, indicating moderately lower profitability relative to the group. The year-over-year change is not available, and the quarter-over-quarter change shows a decline of -1.7%, pointing to a slight recent weakening in earnings efficiency. Combined, the below-median level and small quarterly decline suggest a modest headwind for shareholders, though the drop is minor and does not indicate a drastic deterioration. This metric supports the overall NEUTRAL verdict: the ROE is unimpressive relative to peers, but the lack of a steep trend or a large gap from the median leaves the risk-opportunity balance roughly even.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about CTRA?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are CTRA's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.